Pasar al contenido principal

CONTRIBUCION DE LAS CASPASAS-3 & 7 EN LA ETIOLOGIA DE LA ENFERMEDAD DE ALZHEIMER

PID2019-107948RA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration

  • García-Revilla, Juan
  • Boza-Serrano, Antonio
  • Espinosa-Oliva, Ana M.
  • Sarmiento, Manuel
  • Deierborg, Tomas
  • Ruiz, Rocío
  • Martínez de Pablos, Rocío
  • Burguillos, Miguel Ángel
  • Venero, José L.
The advent of high-throughput single-cell transcriptomic analysis of microglia has revealed different phenotypes that are inherently associated with disease conditions. A common feature of some of these activated phenotypes is the upregulation of galectin-3. Representative examples of these phenotypes include disease-associated microglia (DAM) and white-associated microglia (WAM), whose role(s) in neuroprotection/neurotoxicity is a matter of high interest in the microglia community. In this review, we summarise the main findings that demonstrate the ability of galectin-3 to interact with key pattern recognition receptors, including, among others, TLR4 and TREM2 and the importance of galectin-3 in the regulation of microglia activation. Finally, we discuss increasing evidence supporting the involvement of this lectin in the main neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, traumatic brain injury, and stroke., We thank the Spanish Ministerio de Ciencia, Innovación y Universidades/FEDER/UE RTI2018-098645-B-100, PID2019-107948RA-I00 and RYC-2017-21804; the Agencia Española de Investigación PID2021-124096OB-I00 and PID2021-126090OA-I00; the Spanish Junta de Andalucia /FEDER/EU P18-RT-1372 and the Spanish FEDER I + D + i-USE US-1264806, US-1264152 and US-1265062 from University of Seville. This work has also been supported by the Strategic Research Area MultiPark (Multidisciplinary Research focused on neurodegenerative diseases) at Lund University, the Swedish Alzheimer foundation, the Swedish Brain Foundation, the Crafoord Foundation, the Swedish Dementia Association, the G&J Kock Foundation, the Olle Engkvist Foundation, the Swedish Research Council (Project 2019-06333), the Royal Physiographic Society (42222 and 40594), the A.E. Berger Foundation, the Swedish Parkinson Foundation and the Medical Faculty at Lund University. Open access funding provided by Lund University., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cell Death Related Proteins Beyond Apoptosis in the CNS

  • Bahatyrevich-Kharitonik, Bazhena
  • Medina-Guzman, Rafael
  • Flores-Cortés, Alicia
  • García-Cruzado, Marta
  • Kavanagh, Edel
  • Burguillos, Miguel Ángel
Cell death related (CDR) proteins are a diverse group of proteins whose original function was ascribed to apoptotic cell death signaling. Recently, descriptions of non-apoptotic functions for CDR proteins have increased. In this minireview, we comment on recent studies of CDR proteins outside the field of apoptosis in the CNS, encompassing areas such as the inflammasome and non-apoptotic cell death, cytoskeleton reorganization, synaptic plasticity, mitophagy, neurodegeneration and calcium signaling among others. Furthermore, we discuss the evolution of proteomic techniques used to predict caspase substrates that could potentially explain their non-apoptotic roles. Finally, we address new concepts in the field of non-apoptotic functions of CDR proteins that require further research such the effect of sexual dimorphism on non-apoptotic CDR protein function and the emergence of zymogen-specific caspase functions., This review was funded by the Spanish Ministerio de Ciencia, Innovación y Universidades/FEDER/UE PID 2019-107948RA-I00, FEDER I + D + i-USE US-1265062. MAB. was funded by the Spanish Ministerio de Economia y Competitividad (Programa Ramón y Cajal: RYC-2017-21804). BB-K, was funded by a predoctoral fellowship granted by Spanish Ministerio de Ciencia e Innovación (PRE 2020-095781). AF-C is funded by Fondo Social Europeo (FSE) within Marco del Sistema Nacional de Garantía Juvenil y del Programa Operativo de Empleo Juvenil 2014–2020., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Caspase-3 regulates RNA splicing and mitochondrial dynamics in microglia during Parkinson’s disease

  • Medina-Guzmán, Rafael
  • Bahatyrevich-Kharitonik, Bazhena
  • St-Pierre, Marie-Kim
  • Márquez-Pérez, Sara
  • Gavilán, Elena
  • Coronel-Guisado, Cristóbal
  • Flores-Cortes, Alicia
  • García-Valiente, Rodrigo
  • Argüelles, Sandro
  • Kavanagh, Edel
  • Yang, Yiyi
  • Deierborg, Tomas
  • Venero, José L.
  • González-Aguilera, Cristina
  • Joseph, Bertrand
  • Burguillos, Miguel Ángel
Caspase-3, a cysteine-aspartic protease canonically known for its role in apoptotic cell death, has been implicated in several non-apoptotic functions, particularly in microglia, the brain-resident macrophages. These novel functions appear to depend on distinct levels of caspase-3 activation; however, the role of basal caspase-3 activity remains unclear. Here, we show that basal caspase-3 regulates RNA splicing in microglia, and its deficiency in a Parkinson´s disease (PD) model leads to splicing dysregulation. Loss of basal caspase-3 activity also increases double-stranded RNA (dsRNA) accumulation, inducing a type I interferon response. Additionally, caspase-3 deficiency impairs mitochondrial respiration, reduces ATP production, and causes sex-specific mitochondrial abnormalities, predominantly in female microglia. Together, our findings uncover a non-apoptotic, homeostatic role for basal caspase-3 activity in microglia. Its disruption, such as in PD, may drive key molecular features of neuroinflammation and neurodegeneration, positioning caspase-3 as a critical regulator of microglial function in health and disease., M.A.B. was supported by a Ramón y Cajal Fellowship (RYC-2017-21804, funded by MICIU/AEI/10.13039/501100011033 and the European Social Fund, “Investing in your future”). B.B.-K. was supported by a predoctoral fellowship (PRE2020-095781, funded by MICIU/AEI/10.13039/501100011033 and the European Social Fund, “Investing in your future”). This work was supported by grants US-1265062 (US/Junta/FEDER, EU), PID2019-107948RA-I00 (MICIU/AEI/10.13039/501100011033), PID2022-136485OB-I00 (MICIU/AEI/10.13039/501100011033 and FEDER, EU), and CNS2022-135867 (MICIU/AEI/10.13039/501100011033 and the European Union, NextGenerationEU/PRTR)., Peer reviewed